GeoVax Labs to initiate Phase 2 clinical study of gedeptin
GeoVax Labs (GOVX) announced significant progress in advancing Gedeptin as a cancer therapy. Gedeptin, based on a Gene-Directed Enzyme Prodrug ...
GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial
Represents a Key Step Toward Validating Gedeptin Potential in Solid Tumor Therapy ATLANTA, GA - (NEWMEDIAWIRE) - GeoVax Labs, ...
EQS-News: GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial
EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial 15.01.2025 / 15:05 CET/CEST The issuer is solely responsible for the content ...